| Date | Title | Description |
| 11.02.2026 | Atticus Pharma Announces Clinical Data for ATC-002, a Pharmaceutical Product Candidate for Androgenic Alopecia | GREENVILLE, SC, UNITED STATES, February 11, 2026 /EINPresswire.com/ --
• ATC-002 is a topical treatment designed to stimulate new hair growth in subjects with androgenic alopecia.
• ATC-002 uses Atticus’s proprietary Z-pod® technology to cr... |
| 05.05.2025 | Atticus Pharma Announces Upcoming Late-Breaking Presentation of Collaborative Research at the 82nd Annual SID 2025 | GREENVILLE, SC, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Atticus Pharma Inc, a therapeutics company focused on immunodermatology and associated conditions, today announced the presentation of pre-clinical results in a novel murine m... |
| 14.04.2025 | Atticus Pharma Announces Initiation of the First Human Clinical Trial of ATC-002 | ATC-002 is an Investigational Pharmaceutical Product Candidate for Androgenic Alopecia
GREENVILLE, SC, UNITED STATES, April 14, 2025 /EINPresswire.com/ --
• ATC-002 is a twice-daily treatment designed to stimulate new hair growth in people ... |
